Apr. 17 at 3:34 PM
I am convinced
$SANA has completed its GLP tox studies and tech transfer, and that the IND filing has happened or is imminent, such that an IND clearance will be in May/June (hopefully before the Diabetes Conference the first week of June). The reason I believe this is the August 31 date for Mayo Clinic to exercise its option. That date wasn’t chosen randomly; it must have some meaning. And I believe a material news event will occur by that date (e.g., initial data from SC451). I had not bought shares since September 4 of last year. I added 15,211 sh. today. I now own 300,925 sh. at avg cost of
$4.28.
